| 产品详情 |
| Edit |   |
|---|
| Product Name | (αR,βS)-rel-Bedaquiline |
|---|
| Description | (αR,βS)-rel-Bedaquiline is a promising diarylquinoline candidate in clinical development for the treatment of tuberculosis. (αR,βS)-rel-Bedaquiline inhibits mycobacterial ATP synthase and displays high activity against both drug-susceptible and multidrug-resistant strains of Mycobacterium tuberculosis. |
|---|
| Size | 5mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | (αR,βS)-rel-6-Bromo-α-[2-(dimethylamino)ethyl]-2-methoxy-α-1-naphthalenyl-β-phenyl-3-quinolineethanol |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 167222 |
|---|
| Price | |
|---|
| Order / More Info | (αR,βS)-rel-Bedaquiline from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|